AllianceBernstein
LYRA

AllianceBernstein’s LYRA THERAPEUTICS INC LYRA Stock Holding History

AllianceBernstein’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-662
Closed -$4.18K – 3287
2025
Q1 		$4.18K Hold
662
– – ﹤0.01% 3196
2024
Q4 		$6.84K Hold
662
– – ﹤0.01% 3221
2024
Q3 		$8.51K Hold
662
– – ﹤0.01% 3228
2024
Q2 		$9.16K Buy
+662
New +$74.8K ﹤0.01% 3229
2021
Q2 		– Sell
-1,226
Closed -$711K – 3373
2021
Q1 		$711K Hold
1,226
– – ﹤0.01% 2538
2020
Q4 		$699K Sell
1,226
-8
-0.6% -$4.51K ﹤0.01% 2442
2020
Q3 		$690K Sell
1,234
-653
-35% -$406K ﹤0.01% 2356
2020
Q2 		$1.07M Buy
+1,887
New +$1.38M ﹤0.01% 2170

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein's LYRA Position: Q2 2025 in Review

AllianceBernstein sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2025, closing a stake of 662 shares — an estimated $4.18K sold.

AllianceBernstein first reported a position in LYRA in Q2 2020 and held it in 8 quarters. The position peaked at $1.07M in Q2 2020. 30 funds tracked by Wall St. Rank hold LYRA as of Q2 2025.

  • AllianceBernstein reported no remaining LYRA THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • AllianceBernstein sold 662 LYRA THERAPEUTICS INC shares in Q2 2025, an estimated $4.18K.
  • AllianceBernstein first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 8 quarters.
  • AllianceBernstein's LYRA THERAPEUTICS INC position peaked at $1.07M in Q2 2020.
  • 30 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.